@article{marks:hal-01274886,
TITLE = {Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial},
AUTHOR = {Marks, Reinhard and Tr{\"u}mper, Lorenz and Biyukov, Tsvetan and Patturajan, Meera and Bravo, Marie-Laure Casadebaig and Arcaini, Luca and Trn{\v e}n{\'y},
Marek and Lamy, Thierry and Walewski, Jan and Belada, David and Mayer, Jiri and Radford, John and Jurczak, Wojciech and Morschhauser, Franck and Alexeeva, Julia and Rule, Simon and Afanasyev, Boris and Kaplanov, Kamil and Thyss, Antoine and Kuzmin, Alexej and Voloshin, Sergey and Kuliczkowski, Kazimierz and Giza, Agnieszka and Milpied, Noel and Stelitano, Caterina},
URL = {https://univ-rennes.hal.science/hal-01274886},
JOURNAL = {Lancet Oncology},
PUBLISHER = {Elsevier},
VOLUME = {17},
NUMBER = {3},
PAGES = {319--331},
YEAR = {2016},
MONTH = Mar, DOI = {10.1016/S1470-2045(15)00559-8},
HAL_ID = {hal-01274886},
HAL_VERSION = {v1},
}